ClinicalTrials.Veeva

Menu

SNAGs in Mechanical Neck Pain

R

Raj Nursing and Paramedical College

Status

Completed

Conditions

Neck Pain

Treatments

Other: Ultrasound Therapy, SNAGs

Study type

Interventional

Funder types

Other

Identifiers

NCT04617288
RajNursingParamedicalC

Details and patient eligibility

About

Neck pain is second largest cause of disability worldwide. Chronic neck pain prevalence is 14% which is somewhat higher in females as compared to males. In India reported prevalence is 6%. Therapeutically, neck pain is managed by physiotherapists using rest, stretching and strengthening exercises, educating patient, and intense proprioception and positional exercises.

Full description

To determine the evidences for the efficacy of SNAGs in the Management of Mechanical Neck Pain.

100 patients [Age group 25-45 yrs] who were diagnosed with neck pain, with onset ˃1-3 months (chronic) were randomly assigned to group A receiving conventional Physiotherapy plus SNAGs and group B receiving conventional Physiotherapy plus ultrasound.

Subjects in-group A that received conventional Physiotherapy plus SNAGs showed greater Improvement in pain and range of motion compared with the conventional Physiotherapy plus ultrasound group on 2nd week compared with pretreatment.

The result of study suggests that both SNAGs and Ultrasound groups improves the symptoms of neck pain. Ultrasound group improved the pain symptoms but was too small to reach satisfactory outcome for patients. Based on these results conventional Physiotherapy plus SNAGs should be the treatment of choice for neck pain rather than conventional Physiotherapy plus Ultrasound .

Enrollment

100 patients

Sex

All

Ages

25 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

  • Age group between 20- 45 years.
  • Both Gender male and female.
  • Individuals having localized pain or stiffness in spine or both combined b/w C3 to C7 without upper limbs radiculopathy.
  • Pain reported on VAS score ˃3 in neck region.
  • Patients agree to sign written consent form.

Exclusion Criteria Patients were excluded if they were diagnosed with following conditions for ˃6 months:

  • T.B, carcinoma, heart disease, osteoporosis.
  • Neural disorders due to PIVD.
  • Any trauma or localized infection in neck region.
  • Upper MND, cervical stenosis, metabolic diseases in bone and joint.
  • Hyper flexibility
  • Open sores,
  • Ongoing radiotherapy, chemotherapy, steroid therapy or anticoagulants.
  • Psychiatric diseases such as phobia/obsession, depression.
  • Allergy to hot pack
  • Patients with history of surgery in cervical spine region with in a year.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

100 participants in 2 patient groups

Mean and standard deviations of age and height between group A and B
Experimental group
Description:
100 subjects with a mean age of 30.82±6.75 (group A, 31.42±6.67; group B, 30.82±6.82) ranging from 20 to 45 years, with a mean height of 165.52±7.85 (group A, 164.92±7.79; group B, 166.12±7.87) centimeters
Treatment:
Other: Ultrasound Therapy, SNAGs
Between group comparison of VAS, NDI and ROM
Experimental group
Description:
VAS, NDI and Neck ROM between two groups were compared at pretest (0 day) and posttest (end of two weeks)
Treatment:
Other: Ultrasound Therapy, SNAGs

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems